• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[10例婴儿接种乙肝疫苗后死亡的免疫接种不良反应分析]

[Analysis on the adverse events following immunization of 10 infants death after hepatitis B vaccination].

作者信息

Wang Fu-Zhen, Cui Fu-Qiang, Liu Da-Wei

机构信息

Chinese Center for Disease Control and Prevention, Beijing 100050, China.

出版信息

Zhongguo Yi Miao He Mian Yi. 2009 Feb;15(1):52-7.

PMID:20077677
Abstract

OBJECTIVE

To evaluate the safety of Hepatitis B vaccine by analyzing the 10 infants death after Hepatitis B vaccination.

METHODS

Collect the reporting data from the public health emergencies report system of China Disease Prevention and Control System.

RESULTS

In the 10 death cases after hepatitis B vaccination, 2 cases would be acute anaphylactic shock caused by the vaccination, and the other 8 death cases were not related to vaccination.

CONCLUSIONS

The hepatitis B vaccine of China were safety, there were very few death cases of allergic reactions following hepatitis B vaccination. We should standardize the vaccination in order to reduce the adverse events following immunization.

摘要

目的

通过分析10例乙肝疫苗接种后婴儿死亡情况评估乙肝疫苗的安全性。

方法

收集中国疾病预防控制体系突发公共卫生事件报告系统的报告数据。

结果

在10例乙肝疫苗接种后死亡病例中,2例为接种引起的急性过敏性休克,另外8例死亡病例与接种无关。

结论

中国的乙肝疫苗是安全的,乙肝疫苗接种后过敏反应死亡病例极少。应规范接种操作以减少免疫后不良事件。

相似文献

1
[Analysis on the adverse events following immunization of 10 infants death after hepatitis B vaccination].[10例婴儿接种乙肝疫苗后死亡的免疫接种不良反应分析]
Zhongguo Yi Miao He Mian Yi. 2009 Feb;15(1):52-7.
2
Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.媒体报道中国婴儿乙肝疫苗接种后死亡事件后,公众对疫苗失去信心。
Int J Epidemiol. 2016 Apr;45(2):441-9. doi: 10.1093/ije/dyv349.
3
A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.在一个大型管理式医疗组织中,基于人群的白喉、破伤风、无细胞百日咳、乙型肝炎和灭活脊髓灰质炎联合疫苗上市后安全性评估。
Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.
4
Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.评估 1990-2016 年疫苗不良事件报告系统(VAERS)中孕妇接种乙肝疫苗的安全性。
Vaccine. 2018 Jan 2;36(1):50-54. doi: 10.1016/j.vaccine.2017.11.039. Epub 2017 Nov 27.
5
Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review.疫苗接种后乙肝疫苗不良事件报告:13 年回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2411824. doi: 10.1080/21645515.2024.2411824. Epub 2024 Oct 13.
6
Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.管理式医疗队列中的围产期乙型肝炎传播与疫苗接种时机:对因硫柳汞含量导致新生儿乙型肝炎疫苗接种暂时延迟的评估
Pediatr Infect Dis J. 2007 Apr;26(4):329-33. doi: 10.1097/01.inf.0000258616.12752.51.
7
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.出生时联合皮内注射重组乙肝疫苗和卡介苗的免疫原性及安全性。
Vaccine. 2008 Jan 30;26(5):647-52. doi: 10.1016/j.vaccine.2007.11.048. Epub 2007 Dec 7.
8
A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.一项评估 2、3、4 月龄和 12-18 月龄接种 7 价白喉、破伤风、无细胞百日咳、乙型肝炎、脊髓灰质炎、流感嗜血杆菌和脑膜炎球菌 C 群联合疫苗的免疫原性和安全性的随机对照试验。
Pediatr Infect Dis J. 2013 Jul;32(7):777-85. doi: 10.1097/INF.0b013e31828d6b20.
9
Benefits of early hepatitis B immunization programs for newborns and infants.新生儿和婴儿早期乙肝免疫规划的益处。
Pediatr Infect Dis J. 2008 Oct;27(10):861-9. doi: 10.1097/INF.0b013e318173966f.
10
A review of hepatitis B vaccination.乙肝疫苗综述
Expert Opin Drug Saf. 2003 Mar;2(2):113-22. doi: 10.1517/14740338.2.2.113.